These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 20667441

  • 1. Strain identification of commercial influenza vaccines by mass spectrometry.
    Creskey MC, Smith DG, Cyr TD.
    Anal Biochem; 2010 Nov 15; 406(2):193-203. PubMed ID: 20667441
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC-MSE.
    Creskey MC, Li C, Wang J, Girard M, Lorbetskie B, Gravel C, Farnsworth A, Li X, Smith DG, Cyr TD.
    Vaccine; 2012 Jul 06; 30(32):4762-70. PubMed ID: 22643214
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry.
    Williams TL, Pirkle JL, Barr JR.
    Vaccine; 2012 Mar 23; 30(14):2475-82. PubMed ID: 22197963
    [Abstract] [Full Text] [Related]

  • 4. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C, Shao M, Cui X, Song Y, Li J, Yuan L, Fang H, Liang Z, Cyr TD, Li F, Li X, Wang J.
    Biologicals; 2010 Mar 23; 38(2):284-9. PubMed ID: 20074976
    [Abstract] [Full Text] [Related]

  • 5. Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry.
    Blake TA, Williams TL, Pirkle JL, Barr JR.
    Anal Chem; 2009 Apr 15; 81(8):3109-18. PubMed ID: 19290601
    [Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ, Lee CW, Sylte M, Suarez DL.
    Vaccine; 2009 Oct 19; 27(44):6247-60. PubMed ID: 19686695
    [Abstract] [Full Text] [Related]

  • 7. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.
    Vaccine; 2007 Oct 16; 25(42):7379-84. PubMed ID: 17870216
    [Abstract] [Full Text] [Related]

  • 8. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada.
    Abed Y, Hardy I, Li Y, Boivin G.
    J Med Virol; 2002 Aug 16; 67(4):589-95. PubMed ID: 12116009
    [Abstract] [Full Text] [Related]

  • 9. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC, Johansson BE.
    Virology; 2005 Sep 01; 339(2):273-80. PubMed ID: 15996702
    [Abstract] [Full Text] [Related]

  • 10. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC.
    Vaccine; 2008 May 02; 26(19):2307-13. PubMed ID: 18395947
    [Abstract] [Full Text] [Related]

  • 11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M.
    J Infect Dis; 1999 May 02; 179(5):1132-8. PubMed ID: 10191214
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z, Zhou H, Jin H.
    Vaccine; 2010 May 28; 28(24):4079-85. PubMed ID: 20399830
    [Abstract] [Full Text] [Related]

  • 18. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C, Kurata T, Tamura S.
    Jpn J Infect Dis; 2000 Dec 28; 53(6):219-28. PubMed ID: 11227019
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.